HLA Typing for Transplant Market Analysis

  • Report ID: 2629
  • Published Date: Oct 15, 2024
  • Report Format: PDF, PPT

HLA Typing for Transplant Market Analysis

The HLA typing for transplant market is segmented by technology, by-products, by application & by end-user, out of which, the molecular assay of technology sector segment is anticipated to hold leading shares in the market on account of the benefits offered by molecular assays such as low turnaround time, high procedural efficacy, the study of multiple samples, and real-time sample analysis. On the contrary, the diagnostic segment of the application sector accounted for the largest share owing to the rising adoption of molecular assay procedures for pathogen detection & histocompatibility testing, and the increasing incidence of chronic diseases. Additionally, independent reference laboratories segment of the end-user sector is estimated to witness a robust growth owing to the increasing number of research & development activities outsourced by pharmaceutical & biotechnology, rapid modernization and automation of diagnostic laboratories, and the growing number of organ transplantation procedures.

Our in-depth analysis of the global market includes the following segments:

           By Technology

  • Non-Molecular Assay
  • Molecular Assay

             By Products

  • Instruments
  • Reagents & Consumables
  • Software & Services

 

 

            Application

  • Diagnostic Applications
  • Research Applications

            End-User

  • Independent Reference Laboratories
  • Hospitals & Transplant Centers
  • Research Laboratories
  • Academic Institutions
  • Commercial Service Providers
 
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 2629
  • Published Date: Oct 15, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of HLA typing for transplant is estimated at USD 843.51 million.

HLA Typing for Transplant Market size was over USD 803.65 million in 2023 and is anticipated to cross USD 1.75 billion by 2036, witnessing more than 6.2% CAGR during the forecast period i.e., between 2024-2036.

North America industry is poised to account for largest revenue share by 2036, on account of the presence of a highly developed healthcare system, large volume of organ transplantation procedures performed in the region, high adoption of innovative transplant diagnostic technologies (includes HLA typing) among medical professionals and technological advancements in the field of transplant diagnostics.

The major players in the market are Immucor, Inc., Illumina, Inc., CareDx, Inc., QIAGEN N.V., Bio-Rad Laboratories, Inc., F. Hoffman-La Roche Ltd., Biofortuna Limited, Takara Bio Inc., Omixon Inc., and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample